Ionis announces presentation of positive Phase 2b data for chronic hepatitis B treatment at the EASL International Liver Congress™ ...Middle East

- Interim analysis of B-Clear clinical study of bepirovirsen demonstrated end-of-treatment virologic response (VR) in patients with chronic hepatitis B - Phase 3 clinical study evaluating bepirovirsen as a monotherapy is anticipated to start in the first half of 2023 - GSK to explore...

Hence then, the article about ionis announces presentation of positive phase 2b data for chronic hepatitis b treatment at the easl international liver congress was published today ( Saturday 25/06/2022 - 04:20 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Ionis announces presentation of positive Phase 2b data for chronic hepatitis B treatment at the EASL International Liver Congress™ )

Also on site :

• Russia-Ukraine war: List of key events, day 1,426
• Rangers’ Cody Bradford Targeting Return In May From Elbow Surgery
• '90s Trash Metal Band Releases New Single Ahead of Farewell Album